Alexandra N Donlan

Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial

W. Petri, H. Haughey, Jennie Z. Ma, 2022, medRxiv.